[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-334795-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-334795-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","natural-history-and-prognostic-model-of-untreated-papillary-thyroid-cancer-a-seer-database-analysis","Natural History and Prognostic Model of Untreated Papillary Thyroid Cancer - A SEER Database Analysis","","This investigation uses the SEER database to characterize progression patterns in untreated papillary thyroid cancer (PTC) and to build and validate a prognostic nomogram. Data were drawn from PTC patients diagnosed between 2004 and 2020, with progression intervals estimated via stage-wise median survival differences. Independent prognostic factors were identified using univariate and multivariate Cox regression, then integrated into a nomogram.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/natural-history-and-prognostic-model-of-untreated-papillary-thyroid-cancer-a-seer-database-analysis/334795/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/natural-history-and-prognostic-model-of-untreated-papillary-thyroid-cancer-a-seer-database-analysis/334795.png","ImageObject",300,407,{"name":42,"@type":43},"Eliana","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-05","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What data source and study period were used for the untreated PTC analysis?","Question",{"text":63,"@type":64},"The study extracted cases from the SEER database, focusing on PTC diagnoses from 2004 to 2020.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were disease progression intervals estimated across PTC stages?",{"text":68,"@type":64},"Progression time was estimated by subtracting the median survival time of a more severe stage from the preceding stage’s median survival time.",{"name":70,"@type":61,"acceptedAnswer":71},"Which factors were identified as independent predictors of prognosis in the training set?",{"text":72,"@type":64},"Age, tumor stage, gender, and marital status were identified as independent risk factors, and they were used to construct the nomogram.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},334795,1790821056,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":4},4398048949847,"https://ap-avatar.wpscdn.com/avatar/400002536579ef2da7f?_k=1778318612642679267","| Natural History and Prognostic Model of Untreated Papillary Thyroid Cancer: A SEER Database Analysis | Cancer Control Volume 31: 1–15\u003Cbr>© The Author(s) 2024\u003Cbr>Article reuse guidelines:\u003Cbr>[sagepub.com/journals-permissions](sagepub.com/journals-permissions)\u003Cbr>[DOI: 10.1177/10732748241253956](DOI: 10.1177/10732748241253956)[ ](DOI: 10.1177/10732748241253956)[journals.sagepub.com/home/ccx](journals.sagepub.com/home/ccx)\u003Cbr>\u003Cbr>|\n| --- | --- |\n| Dasong Wang 1 􀀁, Yan Yang1, Yu He 1, Hongwei Yang 1, and Lei Yang 1 􀀁\u003Cbr>Abstract\u003Cbr>Purpose: This investigation leveraged the SEER database to delve into the progression patterns of PTC when left untreated. Furthermore, it aimed to devise and authenticate a nomogram for prognosis prediction for such patients.\u003Cbr>Methods: We extracted data from the SEER database, focusing on PTC-diagnosed individuals from 2004-2020. To discern disease progression intervals, median survival times across stages were gauged, and the disease progression time was estimated by subtracting the median survival time of a more severe stage from its preceding stage. Prognostic determinants in the training set were pinpointed using both univariate and multivariate Cox regression. Using these determinants, a prognostic nomogram was crafted.\u003Cbr>Results: In untreated PTC patients, those in stages I and II had a favorable prognosis, with 10-year overall survival rates of 86.34% and 66.03%, respectively. Patients in stages III and IV had a relatively poorer prognosis. The median survival time of stage III, stage IVA, stage IVB and stage IVC patients was 108months, 43 months, 20 months and 8 months, respectively. The deduced progression intervals from stages III-IVC were 65, 23, and 12 months. In the training set, age, tumor stage, gender, and marital status were identiﬁed as independent risk factors inﬂuencing the prognosis of untreated PTC, and a nomogram was constructed using these variables.\u003Cbr>Conclusion: In the absence of treatment intervention, early-stage PTC progressed slowly with an overall favorable prognosis. However, in mid to advanced-stage PTC, as tumor stage increased, disease progression accelerated, and prognosis gradually worsened. Age, tumor stage, marital status, and gender were independent risk factors inﬂuencing the prognosis of untreated PTC, and the nomogram based on these factors demonstrated good prognostic capability.\u003Cbr>Plain Language Summary\u003Cbr>Purpose: This investigation leveraged the SEER database to delve into the progression patterns of PTC when left untreated. Furthermore, it aimed to devise and authenticate a nomogram for prognosis prediction for such patients.\u003Cbr>Methods: We extracted data from the SEER database, focusing on PTC-diagnosed individuals from 2004-2020. To discern disease progression intervals, median survival times across stages were gauged, and the disease progression time was estimated by subtracting the median survival time of a more severe stage from its preceding stage. Prognostic determinants in the training set were pinpointed using both univariate and multivariate Cox regression. Using these determinants, a prognostic nomogram was crafted. |  |\n| 1 Department of Breast and Thyroid Surgery, Suining Central Hospital, Suining, China\u003Cbr>Corresponding Author:\u003Cbr>Lei Yang, Department of Breast and Thyroid Surgery, Suining Central Hospital, NO.127 Desheng West Road, Chuanshan District, Suining, Sichuan 629000, China.\u003Cbr>Email: [leiyang201608@163.com](leiyang201608@163.com) |  |\n\nCreative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons  \nAttribution-NonCommercial 4.0 License ([https://creativecommons.org/licenses/by-nc/4.0/](https://creativecommons.org/licenses/by-nc/4.0/)) which permits non-commercial use,  \nreproduction and distribution of the work without further permission provided the original work is attributed as speciﬁed on the SAGE and Open Access pages ([https://us.sagepub.com/en-us/nam/open-access-at-sage]","cbCaiuTr9FiqO09V","https://ap.wps.com/l/cbCaiuTr9FiqO09V","pdf",1729523,15,"English","# Abstract\n## Purpose\n## Methods\n## Results\n## Conclusion\n# Introduction\n## Background on thyroid cancer and PTC\n# Methods\n## SEER cohort and progression interval estimation\n## Cox regression and nomogram construction\n# Results\n## Survival by stage and progression intervals\n## Independent risk factors\n# Conclusion\n## Overall interpretation and prognostic value","[{\"question\":\"What data source and study period were used for the untreated PTC analysis?\",\"answer\":\"The study extracted cases from the SEER database, focusing on PTC diagnoses from 2004 to 2020.\"},{\"question\":\"How were disease progression intervals estimated across PTC stages?\",\"answer\":\"Progression time was estimated by subtracting the median survival time of a more severe stage from the preceding stage’s median survival time.\"},{\"question\":\"Which factors were identified as independent predictors of prognosis in the training set?\",\"answer\":\"Age, tumor stage, gender, and marital status were identified as independent risk factors, and they were used to construct the nomogram.\"}]","Natural History and Prognostic Model of Untreated Papillary Thyroid Cancer - A SEER Database Analysis | PDF",1790008390,38]